Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
184 - Do different guidelines exist for promotion of OTC brands to health care professionals with respect to the following:
-
-
comparison of different products based on the approved labelling for parameters such as indications, and the non-clinical claims such as taste,color, odor, dissolution. - Section 5.10.2. of the code does not distinguish between Rx and OTC brands.
-
use of Ad Standards Canada approved consumer taglines for the brand in APS that will be used with healthcare professionals. - No. Audience is an important determinant of advertising regulations. All elements of an ad directed to healthcare professionals are reviewed by PAAB within the provisions of the PAAB Code of Advertising Acceptance (e.g. taglines, non-clinical comparisons, and so on). OTC advertising directed to the general public is reviewed either by Ad Standards Canada or OutReach within the provisions of the Health Canada guidance document "Consumer Advertising Guidelines For Marketed Health Products".
-
